nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluconazole—CYP3A7—Sorafenib—liver cancer	0.127	0.196	CbGbCtD
Fluconazole—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.127	0.196	CbGbCtD
Fluconazole—CYP3A5—Sorafenib—liver cancer	0.0953	0.147	CbGbCtD
Fluconazole—CYP2C19—Sorafenib—liver cancer	0.0769	0.118	CbGbCtD
Fluconazole—CYP2C9—Sorafenib—liver cancer	0.0639	0.0984	CbGbCtD
Fluconazole—ABCB1—Sorafenib—liver cancer	0.062	0.0955	CbGbCtD
Fluconazole—ABCB1—Doxorubicin—liver cancer	0.0376	0.0579	CbGbCtD
Fluconazole—CYP3A4—Sorafenib—liver cancer	0.0372	0.0572	CbGbCtD
Fluconazole—CYP3A4—Doxorubicin—liver cancer	0.0225	0.0347	CbGbCtD
Fluconazole—Rash erythematous—Epirubicin—liver cancer	0.00126	0.00587	CcSEcCtD
Fluconazole—Fungal infection—Epirubicin—liver cancer	0.00125	0.00582	CcSEcCtD
Fluconazole—Erythema multiforme—Sorafenib—liver cancer	0.00124	0.00578	CcSEcCtD
Fluconazole—Cardiac disorder—Sorafenib—liver cancer	0.00122	0.00567	CcSEcCtD
Fluconazole—Flushing—Sorafenib—liver cancer	0.00122	0.00567	CcSEcCtD
Fluconazole—Angiopathy—Sorafenib—liver cancer	0.00119	0.00554	CcSEcCtD
Fluconazole—Immune system disorder—Sorafenib—liver cancer	0.00118	0.00552	CcSEcCtD
Fluconazole—Rigors—Epirubicin—liver cancer	0.00118	0.00551	CcSEcCtD
Fluconazole—Mediastinal disorder—Sorafenib—liver cancer	0.00118	0.0055	CcSEcCtD
Fluconazole—Scotoma—Doxorubicin—liver cancer	0.00118	0.00548	CcSEcCtD
Fluconazole—Rash erythematous—Doxorubicin—liver cancer	0.00117	0.00543	CcSEcCtD
Fluconazole—Alopecia—Sorafenib—liver cancer	0.00116	0.0054	CcSEcCtD
Fluconazole—Fungal infection—Doxorubicin—liver cancer	0.00116	0.00539	CcSEcCtD
Fluconazole—Mental disorder—Sorafenib—liver cancer	0.00115	0.00535	CcSEcCtD
Fluconazole—Liver injury—Epirubicin—liver cancer	0.00115	0.00534	CcSEcCtD
Fluconazole—Malnutrition—Sorafenib—liver cancer	0.00114	0.00532	CcSEcCtD
Fluconazole—Neoplasm malignant—Epirubicin—liver cancer	0.00113	0.00526	CcSEcCtD
Fluconazole—Dysgeusia—Sorafenib—liver cancer	0.00112	0.00521	CcSEcCtD
Fluconazole—Cardiovascular disorder—Epirubicin—liver cancer	0.0011	0.00512	CcSEcCtD
Fluconazole—Rigors—Doxorubicin—liver cancer	0.00109	0.00509	CcSEcCtD
Fluconazole—Liver injury—Doxorubicin—liver cancer	0.00106	0.00494	CcSEcCtD
Fluconazole—Anaemia—Sorafenib—liver cancer	0.00106	0.00491	CcSEcCtD
Fluconazole—Lacrimation increased—Epirubicin—liver cancer	0.00105	0.00488	CcSEcCtD
Fluconazole—Herpes simplex—Epirubicin—liver cancer	0.00105	0.00488	CcSEcCtD
Fluconazole—Neoplasm malignant—Doxorubicin—liver cancer	0.00105	0.00487	CcSEcCtD
Fluconazole—Angioedema—Sorafenib—liver cancer	0.00104	0.00486	CcSEcCtD
Fluconazole—Leukopenia—Sorafenib—liver cancer	0.00102	0.00476	CcSEcCtD
Fluconazole—Blood bilirubin increased—Epirubicin—liver cancer	0.00102	0.00475	CcSEcCtD
Fluconazole—Cardiovascular disorder—Doxorubicin—liver cancer	0.00102	0.00473	CcSEcCtD
Fluconazole—Hypertension—Sorafenib—liver cancer	0.000986	0.00459	CcSEcCtD
Fluconazole—Myalgia—Sorafenib—liver cancer	0.000972	0.00453	CcSEcCtD
Fluconazole—Lacrimation increased—Doxorubicin—liver cancer	0.000969	0.00451	CcSEcCtD
Fluconazole—Herpes simplex—Doxorubicin—liver cancer	0.000969	0.00451	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000965	0.0045	CcSEcCtD
Fluconazole—Hepatocellular injury—Epirubicin—liver cancer	0.000965	0.0045	CcSEcCtD
Fluconazole—Vaginal inflammation—Epirubicin—liver cancer	0.000965	0.0045	CcSEcCtD
Fluconazole—Phosphatase alkaline increased—Epirubicin—liver cancer	0.000965	0.0045	CcSEcCtD
Fluconazole—Dry mouth—Sorafenib—liver cancer	0.000951	0.00443	CcSEcCtD
Fluconazole—Blood bilirubin increased—Doxorubicin—liver cancer	0.000944	0.0044	CcSEcCtD
Fluconazole—Salivary hypersecretion—Epirubicin—liver cancer	0.000938	0.00437	CcSEcCtD
Fluconazole—Anaphylactic shock—Sorafenib—liver cancer	0.000932	0.00434	CcSEcCtD
Fluconazole—Nervous system disorder—Sorafenib—liver cancer	0.000914	0.00426	CcSEcCtD
Fluconazole—Thrombocytopenia—Sorafenib—liver cancer	0.000912	0.00425	CcSEcCtD
Fluconazole—Vaginal infection—Epirubicin—liver cancer	0.000911	0.00424	CcSEcCtD
Fluconazole—Skin disorder—Sorafenib—liver cancer	0.000905	0.00422	CcSEcCtD
Fluconazole—Hepatocellular injury—Doxorubicin—liver cancer	0.000893	0.00416	CcSEcCtD
Fluconazole—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.000893	0.00416	CcSEcCtD
Fluconazole—Vaginal inflammation—Doxorubicin—liver cancer	0.000893	0.00416	CcSEcCtD
Fluconazole—Anorexia—Sorafenib—liver cancer	0.000888	0.00414	CcSEcCtD
Fluconazole—Salivary hypersecretion—Doxorubicin—liver cancer	0.000867	0.00404	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000849	0.00395	CcSEcCtD
Fluconazole—Hypertonia—Epirubicin—liver cancer	0.000846	0.00394	CcSEcCtD
Fluconazole—Vaginal infection—Doxorubicin—liver cancer	0.000843	0.00393	CcSEcCtD
Fluconazole—Abnormal vision—Epirubicin—liver cancer	0.000842	0.00392	CcSEcCtD
Fluconazole—Sepsis—Epirubicin—liver cancer	0.000838	0.0039	CcSEcCtD
Fluconazole—Dyspepsia—Sorafenib—liver cancer	0.00082	0.00382	CcSEcCtD
Fluconazole—Decreased appetite—Sorafenib—liver cancer	0.00081	0.00377	CcSEcCtD
Fluconazole—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.000806	0.00375	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Sorafenib—liver cancer	0.000805	0.00375	CcSEcCtD
Fluconazole—Fatigue—Sorafenib—liver cancer	0.000803	0.00374	CcSEcCtD
Fluconazole—Pain—Sorafenib—liver cancer	0.000797	0.00371	CcSEcCtD
Fluconazole—Constipation—Sorafenib—liver cancer	0.000797	0.00371	CcSEcCtD
Fluconazole—Vascular purpura—Epirubicin—liver cancer	0.000783	0.00365	CcSEcCtD
Fluconazole—Hypertonia—Doxorubicin—liver cancer	0.000783	0.00365	CcSEcCtD
Fluconazole—Hepatic failure—Epirubicin—liver cancer	0.00078	0.00363	CcSEcCtD
Fluconazole—Abnormal vision—Doxorubicin—liver cancer	0.000779	0.00363	CcSEcCtD
Fluconazole—Sepsis—Doxorubicin—liver cancer	0.000775	0.00361	CcSEcCtD
Fluconazole—Gastrointestinal pain—Sorafenib—liver cancer	0.000762	0.00355	CcSEcCtD
Fluconazole—Hot flush—Epirubicin—liver cancer	0.000749	0.00349	CcSEcCtD
Fluconazole—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.000745	0.00347	CcSEcCtD
Fluconazole—Menopausal symptoms—Epirubicin—liver cancer	0.000743	0.00346	CcSEcCtD
Fluconazole—Urticaria—Sorafenib—liver cancer	0.00074	0.00345	CcSEcCtD
Fluconazole—Abdominal pain—Sorafenib—liver cancer	0.000737	0.00343	CcSEcCtD
Fluconazole—Body temperature increased—Sorafenib—liver cancer	0.000737	0.00343	CcSEcCtD
Fluconazole—Purpura—Epirubicin—liver cancer	0.000727	0.00339	CcSEcCtD
Fluconazole—Vascular purpura—Doxorubicin—liver cancer	0.000725	0.00338	CcSEcCtD
Fluconazole—Hepatic failure—Doxorubicin—liver cancer	0.000721	0.00336	CcSEcCtD
Fluconazole—Hot flush—Doxorubicin—liver cancer	0.000693	0.00323	CcSEcCtD
Fluconazole—Menopausal symptoms—Doxorubicin—liver cancer	0.000687	0.0032	CcSEcCtD
Fluconazole—Hypersensitivity—Sorafenib—liver cancer	0.000687	0.0032	CcSEcCtD
Fluconazole—Face oedema—Epirubicin—liver cancer	0.000677	0.00315	CcSEcCtD
Fluconazole—Purpura—Doxorubicin—liver cancer	0.000673	0.00313	CcSEcCtD
Fluconazole—Asthenia—Sorafenib—liver cancer	0.000669	0.00311	CcSEcCtD
Fluconazole—Pruritus—Sorafenib—liver cancer	0.000659	0.00307	CcSEcCtD
Fluconazole—Ataxia—Epirubicin—liver cancer	0.000659	0.00307	CcSEcCtD
Fluconazole—Dry skin—Epirubicin—liver cancer	0.000642	0.00299	CcSEcCtD
Fluconazole—Hypokalaemia—Epirubicin—liver cancer	0.000638	0.00297	CcSEcCtD
Fluconazole—Diarrhoea—Sorafenib—liver cancer	0.000638	0.00297	CcSEcCtD
Fluconazole—Breast disorder—Epirubicin—liver cancer	0.000633	0.00295	CcSEcCtD
Fluconazole—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000631	0.00294	CcSEcCtD
Fluconazole—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000631	0.00294	CcSEcCtD
Fluconazole—Face oedema—Doxorubicin—liver cancer	0.000626	0.00291	CcSEcCtD
Fluconazole—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000618	0.00288	CcSEcCtD
Fluconazole—Dizziness—Sorafenib—liver cancer	0.000616	0.00287	CcSEcCtD
Fluconazole—Ataxia—Doxorubicin—liver cancer	0.00061	0.00284	CcSEcCtD
Fluconazole—Dry skin—Doxorubicin—liver cancer	0.000594	0.00277	CcSEcCtD
Fluconazole—Vomiting—Sorafenib—liver cancer	0.000593	0.00276	CcSEcCtD
Fluconazole—Hypokalaemia—Doxorubicin—liver cancer	0.00059	0.00275	CcSEcCtD
Fluconazole—Rash—Sorafenib—liver cancer	0.000588	0.00274	CcSEcCtD
Fluconazole—Dermatitis—Sorafenib—liver cancer	0.000587	0.00273	CcSEcCtD
Fluconazole—Breast disorder—Doxorubicin—liver cancer	0.000586	0.00273	CcSEcCtD
Fluconazole—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000584	0.00272	CcSEcCtD
Fluconazole—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000584	0.00272	CcSEcCtD
Fluconazole—Headache—Sorafenib—liver cancer	0.000584	0.00272	CcSEcCtD
Fluconazole—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000572	0.00266	CcSEcCtD
Fluconazole—Neutropenia—Epirubicin—liver cancer	0.000566	0.00264	CcSEcCtD
Fluconazole—Nausea—Sorafenib—liver cancer	0.000554	0.00258	CcSEcCtD
Fluconazole—Infestation NOS—Epirubicin—liver cancer	0.00054	0.00251	CcSEcCtD
Fluconazole—Infestation—Epirubicin—liver cancer	0.00054	0.00251	CcSEcCtD
Fluconazole—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000535	0.00249	CcSEcCtD
Fluconazole—Jaundice—Epirubicin—liver cancer	0.000526	0.00245	CcSEcCtD
Fluconazole—Stomatitis—Epirubicin—liver cancer	0.000526	0.00245	CcSEcCtD
Fluconazole—Neutropenia—Doxorubicin—liver cancer	0.000524	0.00244	CcSEcCtD
Fluconazole—Hepatobiliary disease—Epirubicin—liver cancer	0.000511	0.00238	CcSEcCtD
Fluconazole—Agranulocytosis—Epirubicin—liver cancer	0.000504	0.00235	CcSEcCtD
Fluconazole—Infestation—Doxorubicin—liver cancer	0.0005	0.00233	CcSEcCtD
Fluconazole—Infestation NOS—Doxorubicin—liver cancer	0.0005	0.00233	CcSEcCtD
Fluconazole—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000495	0.00231	CcSEcCtD
Fluconazole—Stomatitis—Doxorubicin—liver cancer	0.000487	0.00227	CcSEcCtD
Fluconazole—Jaundice—Doxorubicin—liver cancer	0.000487	0.00227	CcSEcCtD
Fluconazole—Pharyngitis—Epirubicin—liver cancer	0.000481	0.00224	CcSEcCtD
Fluconazole—Urinary tract disorder—Epirubicin—liver cancer	0.000479	0.00223	CcSEcCtD
Fluconazole—Connective tissue disorder—Epirubicin—liver cancer	0.000476	0.00222	CcSEcCtD
Fluconazole—Urethral disorder—Epirubicin—liver cancer	0.000475	0.00221	CcSEcCtD
Fluconazole—Hepatobiliary disease—Doxorubicin—liver cancer	0.000473	0.0022	CcSEcCtD
Fluconazole—Visual impairment—Epirubicin—liver cancer	0.000467	0.00218	CcSEcCtD
Fluconazole—Agranulocytosis—Doxorubicin—liver cancer	0.000466	0.00217	CcSEcCtD
Fluconazole—Erythema multiforme—Epirubicin—liver cancer	0.000458	0.00213	CcSEcCtD
Fluconazole—Eye disorder—Epirubicin—liver cancer	0.000453	0.00211	CcSEcCtD
Fluconazole—Cardiac disorder—Epirubicin—liver cancer	0.00045	0.00209	CcSEcCtD
Fluconazole—Flushing—Epirubicin—liver cancer	0.00045	0.00209	CcSEcCtD
Fluconazole—Pharyngitis—Doxorubicin—liver cancer	0.000445	0.00207	CcSEcCtD
Fluconazole—Urinary tract disorder—Doxorubicin—liver cancer	0.000443	0.00206	CcSEcCtD
Fluconazole—Connective tissue disorder—Doxorubicin—liver cancer	0.000441	0.00205	CcSEcCtD
Fluconazole—Angiopathy—Epirubicin—liver cancer	0.00044	0.00205	CcSEcCtD
Fluconazole—Urethral disorder—Doxorubicin—liver cancer	0.00044	0.00205	CcSEcCtD
Fluconazole—Immune system disorder—Epirubicin—liver cancer	0.000438	0.00204	CcSEcCtD
Fluconazole—Mediastinal disorder—Epirubicin—liver cancer	0.000437	0.00203	CcSEcCtD
Fluconazole—Chills—Epirubicin—liver cancer	0.000435	0.00203	CcSEcCtD
Fluconazole—Visual impairment—Doxorubicin—liver cancer	0.000432	0.00201	CcSEcCtD
Fluconazole—Alopecia—Epirubicin—liver cancer	0.000428	0.00199	CcSEcCtD
Fluconazole—Mental disorder—Epirubicin—liver cancer	0.000425	0.00198	CcSEcCtD
Fluconazole—Erythema multiforme—Doxorubicin—liver cancer	0.000424	0.00197	CcSEcCtD
Fluconazole—Malnutrition—Epirubicin—liver cancer	0.000422	0.00197	CcSEcCtD
Fluconazole—Eye disorder—Doxorubicin—liver cancer	0.000419	0.00195	CcSEcCtD
Fluconazole—Cardiac disorder—Doxorubicin—liver cancer	0.000416	0.00194	CcSEcCtD
Fluconazole—Flushing—Doxorubicin—liver cancer	0.000416	0.00194	CcSEcCtD
Fluconazole—Flatulence—Epirubicin—liver cancer	0.000416	0.00194	CcSEcCtD
Fluconazole—Tension—Epirubicin—liver cancer	0.000414	0.00193	CcSEcCtD
Fluconazole—Dysgeusia—Epirubicin—liver cancer	0.000413	0.00192	CcSEcCtD
Fluconazole—Nervousness—Epirubicin—liver cancer	0.00041	0.00191	CcSEcCtD
Fluconazole—Back pain—Epirubicin—liver cancer	0.000408	0.0019	CcSEcCtD
Fluconazole—Angiopathy—Doxorubicin—liver cancer	0.000407	0.0019	CcSEcCtD
Fluconazole—Immune system disorder—Doxorubicin—liver cancer	0.000405	0.00189	CcSEcCtD
Fluconazole—Mediastinal disorder—Doxorubicin—liver cancer	0.000404	0.00188	CcSEcCtD
Fluconazole—Chills—Doxorubicin—liver cancer	0.000402	0.00187	CcSEcCtD
Fluconazole—Alopecia—Doxorubicin—liver cancer	0.000396	0.00185	CcSEcCtD
Fluconazole—Mental disorder—Doxorubicin—liver cancer	0.000393	0.00183	CcSEcCtD
Fluconazole—Ill-defined disorder—Epirubicin—liver cancer	0.000392	0.00182	CcSEcCtD
Fluconazole—Malnutrition—Doxorubicin—liver cancer	0.00039	0.00182	CcSEcCtD
Fluconazole—Anaemia—Epirubicin—liver cancer	0.00039	0.00182	CcSEcCtD
Fluconazole—Agitation—Epirubicin—liver cancer	0.000388	0.00181	CcSEcCtD
Fluconazole—Flatulence—Doxorubicin—liver cancer	0.000385	0.00179	CcSEcCtD
Fluconazole—Tension—Doxorubicin—liver cancer	0.000383	0.00178	CcSEcCtD
Fluconazole—Dysgeusia—Doxorubicin—liver cancer	0.000382	0.00178	CcSEcCtD
Fluconazole—Malaise—Epirubicin—liver cancer	0.000381	0.00177	CcSEcCtD
Fluconazole—Nervousness—Doxorubicin—liver cancer	0.000379	0.00177	CcSEcCtD
Fluconazole—Vertigo—Epirubicin—liver cancer	0.000379	0.00177	CcSEcCtD
Fluconazole—Leukopenia—Epirubicin—liver cancer	0.000378	0.00176	CcSEcCtD
Fluconazole—Back pain—Doxorubicin—liver cancer	0.000378	0.00176	CcSEcCtD
Fluconazole—Convulsion—Epirubicin—liver cancer	0.000366	0.0017	CcSEcCtD
Fluconazole—Hypertension—Epirubicin—liver cancer	0.000364	0.0017	CcSEcCtD
Fluconazole—Ill-defined disorder—Doxorubicin—liver cancer	0.000362	0.00169	CcSEcCtD
Fluconazole—Anaemia—Doxorubicin—liver cancer	0.000361	0.00168	CcSEcCtD
Fluconazole—Myalgia—Epirubicin—liver cancer	0.000359	0.00167	CcSEcCtD
Fluconazole—Agitation—Doxorubicin—liver cancer	0.000359	0.00167	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000357	0.00166	CcSEcCtD
Fluconazole—Discomfort—Epirubicin—liver cancer	0.000355	0.00165	CcSEcCtD
Fluconazole—Malaise—Doxorubicin—liver cancer	0.000352	0.00164	CcSEcCtD
Fluconazole—Dry mouth—Epirubicin—liver cancer	0.000351	0.00164	CcSEcCtD
Fluconazole—Vertigo—Doxorubicin—liver cancer	0.000351	0.00163	CcSEcCtD
Fluconazole—Leukopenia—Doxorubicin—liver cancer	0.00035	0.00163	CcSEcCtD
Fluconazole—Anaphylactic shock—Epirubicin—liver cancer	0.000344	0.0016	CcSEcCtD
Fluconazole—Convulsion—Doxorubicin—liver cancer	0.000338	0.00158	CcSEcCtD
Fluconazole—Nervous system disorder—Epirubicin—liver cancer	0.000338	0.00157	CcSEcCtD
Fluconazole—Thrombocytopenia—Epirubicin—liver cancer	0.000337	0.00157	CcSEcCtD
Fluconazole—Hypertension—Doxorubicin—liver cancer	0.000337	0.00157	CcSEcCtD
Fluconazole—Skin disorder—Epirubicin—liver cancer	0.000335	0.00156	CcSEcCtD
Fluconazole—Hyperhidrosis—Epirubicin—liver cancer	0.000333	0.00155	CcSEcCtD
Fluconazole—Myalgia—Doxorubicin—liver cancer	0.000332	0.00155	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00033	0.00154	CcSEcCtD
Fluconazole—Discomfort—Doxorubicin—liver cancer	0.000328	0.00153	CcSEcCtD
Fluconazole—Anorexia—Epirubicin—liver cancer	0.000328	0.00153	CcSEcCtD
Fluconazole—Dry mouth—Doxorubicin—liver cancer	0.000325	0.00151	CcSEcCtD
Fluconazole—Anaphylactic shock—Doxorubicin—liver cancer	0.000319	0.00148	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000314	0.00146	CcSEcCtD
Fluconazole—Nervous system disorder—Doxorubicin—liver cancer	0.000313	0.00146	CcSEcCtD
Fluconazole—Thrombocytopenia—Doxorubicin—liver cancer	0.000312	0.00145	CcSEcCtD
Fluconazole—Insomnia—Epirubicin—liver cancer	0.000312	0.00145	CcSEcCtD
Fluconazole—Skin disorder—Doxorubicin—liver cancer	0.00031	0.00144	CcSEcCtD
Fluconazole—Paraesthesia—Epirubicin—liver cancer	0.000309	0.00144	CcSEcCtD
Fluconazole—Hyperhidrosis—Doxorubicin—liver cancer	0.000308	0.00143	CcSEcCtD
Fluconazole—Somnolence—Epirubicin—liver cancer	0.000306	0.00143	CcSEcCtD
Fluconazole—Anorexia—Doxorubicin—liver cancer	0.000304	0.00141	CcSEcCtD
Fluconazole—Dyspepsia—Epirubicin—liver cancer	0.000303	0.00141	CcSEcCtD
Fluconazole—Decreased appetite—Epirubicin—liver cancer	0.000299	0.00139	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Epirubicin—liver cancer	0.000297	0.00138	CcSEcCtD
Fluconazole—Fatigue—Epirubicin—liver cancer	0.000297	0.00138	CcSEcCtD
Fluconazole—Pain—Epirubicin—liver cancer	0.000295	0.00137	CcSEcCtD
Fluconazole—Constipation—Epirubicin—liver cancer	0.000295	0.00137	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00029	0.00135	CcSEcCtD
Fluconazole—Insomnia—Doxorubicin—liver cancer	0.000288	0.00134	CcSEcCtD
Fluconazole—Paraesthesia—Doxorubicin—liver cancer	0.000286	0.00133	CcSEcCtD
Fluconazole—Feeling abnormal—Epirubicin—liver cancer	0.000284	0.00132	CcSEcCtD
Fluconazole—Somnolence—Doxorubicin—liver cancer	0.000283	0.00132	CcSEcCtD
Fluconazole—Gastrointestinal pain—Epirubicin—liver cancer	0.000282	0.00131	CcSEcCtD
Fluconazole—Dyspepsia—Doxorubicin—liver cancer	0.000281	0.00131	CcSEcCtD
Fluconazole—Decreased appetite—Doxorubicin—liver cancer	0.000277	0.00129	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000275	0.00128	CcSEcCtD
Fluconazole—Fatigue—Doxorubicin—liver cancer	0.000275	0.00128	CcSEcCtD
Fluconazole—Urticaria—Epirubicin—liver cancer	0.000274	0.00127	CcSEcCtD
Fluconazole—Constipation—Doxorubicin—liver cancer	0.000273	0.00127	CcSEcCtD
Fluconazole—Pain—Doxorubicin—liver cancer	0.000273	0.00127	CcSEcCtD
Fluconazole—Body temperature increased—Epirubicin—liver cancer	0.000272	0.00127	CcSEcCtD
Fluconazole—Abdominal pain—Epirubicin—liver cancer	0.000272	0.00127	CcSEcCtD
Fluconazole—Feeling abnormal—Doxorubicin—liver cancer	0.000263	0.00122	CcSEcCtD
Fluconazole—Gastrointestinal pain—Doxorubicin—liver cancer	0.000261	0.00121	CcSEcCtD
Fluconazole—Hypersensitivity—Epirubicin—liver cancer	0.000254	0.00118	CcSEcCtD
Fluconazole—Urticaria—Doxorubicin—liver cancer	0.000253	0.00118	CcSEcCtD
Fluconazole—Abdominal pain—Doxorubicin—liver cancer	0.000252	0.00117	CcSEcCtD
Fluconazole—Body temperature increased—Doxorubicin—liver cancer	0.000252	0.00117	CcSEcCtD
Fluconazole—Asthenia—Epirubicin—liver cancer	0.000247	0.00115	CcSEcCtD
Fluconazole—Pruritus—Epirubicin—liver cancer	0.000244	0.00113	CcSEcCtD
Fluconazole—Diarrhoea—Epirubicin—liver cancer	0.000236	0.0011	CcSEcCtD
Fluconazole—Hypersensitivity—Doxorubicin—liver cancer	0.000235	0.00109	CcSEcCtD
Fluconazole—Asthenia—Doxorubicin—liver cancer	0.000229	0.00106	CcSEcCtD
Fluconazole—Dizziness—Epirubicin—liver cancer	0.000228	0.00106	CcSEcCtD
Fluconazole—Pruritus—Doxorubicin—liver cancer	0.000225	0.00105	CcSEcCtD
Fluconazole—Vomiting—Epirubicin—liver cancer	0.000219	0.00102	CcSEcCtD
Fluconazole—Diarrhoea—Doxorubicin—liver cancer	0.000218	0.00102	CcSEcCtD
Fluconazole—Rash—Epirubicin—liver cancer	0.000217	0.00101	CcSEcCtD
Fluconazole—Dermatitis—Epirubicin—liver cancer	0.000217	0.00101	CcSEcCtD
Fluconazole—Headache—Epirubicin—liver cancer	0.000216	0.001	CcSEcCtD
Fluconazole—Dizziness—Doxorubicin—liver cancer	0.000211	0.000981	CcSEcCtD
Fluconazole—Nausea—Epirubicin—liver cancer	0.000205	0.000953	CcSEcCtD
Fluconazole—Vomiting—Doxorubicin—liver cancer	0.000203	0.000943	CcSEcCtD
Fluconazole—Rash—Doxorubicin—liver cancer	0.000201	0.000936	CcSEcCtD
Fluconazole—Dermatitis—Doxorubicin—liver cancer	0.000201	0.000935	CcSEcCtD
Fluconazole—Headache—Doxorubicin—liver cancer	0.0002	0.00093	CcSEcCtD
Fluconazole—Nausea—Doxorubicin—liver cancer	0.000189	0.000881	CcSEcCtD
Fluconazole—ABCB1—Metabolism—EPT1—liver cancer	6.37e-05	0.00047	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—GSTA2—liver cancer	6.36e-05	0.000469	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	6.35e-05	0.000468	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—UGDH—liver cancer	6.33e-05	0.000467	CbGpPWpGaD
Fluconazole—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	6.32e-05	0.000466	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—TAT—liver cancer	6.19e-05	0.000456	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—GSTA1—liver cancer	6.14e-05	0.000452	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—GSTM1—liver cancer	6.09e-05	0.000449	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	6.09e-05	0.000449	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—NAT2—liver cancer	6.07e-05	0.000447	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—TAT—liver cancer	6.04e-05	0.000445	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—EPT1—liver cancer	5.95e-05	0.000439	CbGpPWpGaD
Fluconazole—CYP3A4—Biological oxidations—GSTM1—liver cancer	5.89e-05	0.000434	CbGpPWpGaD
Fluconazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	5.83e-05	0.000429	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—ALDOB—liver cancer	5.82e-05	0.000429	CbGpPWpGaD
Fluconazole—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	5.81e-05	0.000428	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—CYP1A1—liver cancer	5.77e-05	0.000425	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—TAT—liver cancer	5.64e-05	0.000416	CbGpPWpGaD
Fluconazole—CYP3A4—Biological oxidations—CYP1A1—liver cancer	5.58e-05	0.000411	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	5.55e-05	0.000409	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—CRABP1—liver cancer	5.55e-05	0.000409	CbGpPWpGaD
Fluconazole—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	5.5e-05	0.000406	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GLUL—liver cancer	5.44e-05	0.000401	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—CPT1B—liver cancer	5.44e-05	0.000401	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—MTHFR—liver cancer	5.38e-05	0.000397	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—PPARA—liver cancer	5.28e-05	0.000389	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—NR1H4—liver cancer	5.25e-05	0.000387	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GSTA3—liver cancer	5.16e-05	0.00038	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	5.12e-05	0.000378	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—HPGDS—liver cancer	4.85e-05	0.000358	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.74e-05	0.00035	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GSTA4—liver cancer	4.72e-05	0.000348	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	4.69e-05	0.000346	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	4.6e-05	0.000339	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GSTA2—liver cancer	4.6e-05	0.000339	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.55e-05	0.000336	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—PIK3CG—liver cancer	4.52e-05	0.000333	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	4.48e-05	0.00033	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	4.47e-05	0.000329	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GSTA1—liver cancer	4.43e-05	0.000327	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	4.43e-05	0.000327	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—NAT2—liver cancer	4.39e-05	0.000323	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—PPARG—liver cancer	4.36e-05	0.000322	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	4.33e-05	0.000319	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—PSMD10—liver cancer	4.32e-05	0.000319	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—PSMA4—liver cancer	4.32e-05	0.000319	CbGpPWpGaD
Fluconazole—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	4.31e-05	0.000318	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	4.23e-05	0.000312	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—CPT1B—liver cancer	4.21e-05	0.00031	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GLUL—liver cancer	4.21e-05	0.00031	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—GOT2—liver cancer	4.2e-05	0.00031	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—ALDOB—liver cancer	4.2e-05	0.00031	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—UGDH—liver cancer	4.17e-05	0.000308	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.15e-05	0.000306	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GLUL—liver cancer	4.11e-05	0.000303	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—CPT1B—liver cancer	4.11e-05	0.000303	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—NR1H4—liver cancer	4.06e-05	0.000299	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—CRABP1—liver cancer	4.01e-05	0.000296	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GSTA3—liver cancer	3.99e-05	0.000294	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—PIK3CD—liver cancer	3.97e-05	0.000293	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—NR1H4—liver cancer	3.96e-05	0.000292	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—CYP2E1—liver cancer	3.95e-05	0.000291	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—EPT1—liver cancer	3.92e-05	0.000289	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—ALB—liver cancer	3.92e-05	0.000289	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	3.9e-05	0.000288	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GSTA3—liver cancer	3.89e-05	0.000287	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—CPT1B—liver cancer	3.84e-05	0.000283	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GLUL—liver cancer	3.84e-05	0.000283	CbGpPWpGaD
Fluconazole—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	3.74e-05	0.000276	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—TAT—liver cancer	3.72e-05	0.000274	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—CYCS—liver cancer	3.7e-05	0.000273	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—NR1H4—liver cancer	3.7e-05	0.000273	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GSTA4—liver cancer	3.65e-05	0.000269	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GSTA3—liver cancer	3.64e-05	0.000268	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—GGT1—liver cancer	3.63e-05	0.000268	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—GOT1—liver cancer	3.63e-05	0.000268	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	3.59e-05	0.000265	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	3.58e-05	0.000264	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.56e-05	0.000263	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GSTA4—liver cancer	3.56e-05	0.000262	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GSTA2—liver cancer	3.55e-05	0.000262	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—HPGDS—liver cancer	3.51e-05	0.000258	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GSTA2—liver cancer	3.47e-05	0.000256	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—PIK3CB—liver cancer	3.46e-05	0.000255	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GSTA1—liver cancer	3.43e-05	0.000253	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—NAT2—liver cancer	3.39e-05	0.00025	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GSTA1—liver cancer	3.35e-05	0.000247	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	3.34e-05	0.000247	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GSTA4—liver cancer	3.33e-05	0.000245	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	3.32e-05	0.000245	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—NAT2—liver cancer	3.31e-05	0.000244	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—GSTP1—liver cancer	3.26e-05	0.00024	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.26e-05	0.00024	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—ALDOB—liver cancer	3.25e-05	0.00024	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.25e-05	0.00024	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GSTA2—liver cancer	3.24e-05	0.000239	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—HMOX1—liver cancer	3.22e-05	0.000237	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—ALDOB—liver cancer	3.17e-05	0.000234	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GSTA1—liver cancer	3.13e-05	0.00023	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—PSMA4—liver cancer	3.12e-05	0.00023	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—PSMD10—liver cancer	3.12e-05	0.00023	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—CRABP1—liver cancer	3.1e-05	0.000229	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—NAT2—liver cancer	3.09e-05	0.000228	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	3.05e-05	0.000225	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GOT2—liver cancer	3.04e-05	0.000224	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—CRABP1—liver cancer	3.03e-05	0.000223	CbGpPWpGaD
Fluconazole—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	3.03e-05	0.000223	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—GSTM1—liver cancer	3e-05	0.000221	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.97e-05	0.000219	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—ALDOB—liver cancer	2.96e-05	0.000218	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.95e-05	0.000217	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—CYP2E1—liver cancer	2.86e-05	0.000211	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—CYP1A1—liver cancer	2.84e-05	0.000209	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—CRABP1—liver cancer	2.83e-05	0.000208	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.79e-05	0.000206	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—HPGDS—liver cancer	2.71e-05	0.0002	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.69e-05	0.000199	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—CYCS—liver cancer	2.67e-05	0.000197	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—MTHFR—liver cancer	2.65e-05	0.000195	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—HPGDS—liver cancer	2.65e-05	0.000195	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GOT1—liver cancer	2.62e-05	0.000193	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GGT1—liver cancer	2.62e-05	0.000193	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—PPARA—liver cancer	2.6e-05	0.000192	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.55e-05	0.000188	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—CPT1B—liver cancer	2.53e-05	0.000186	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GLUL—liver cancer	2.53e-05	0.000186	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.49e-05	0.000184	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—HPGDS—liver cancer	2.47e-05	0.000182	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.46e-05	0.000181	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.45e-05	0.000181	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—NR1H4—liver cancer	2.44e-05	0.00018	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.42e-05	0.000179	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—PSMA4—liver cancer	2.42e-05	0.000178	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—PSMD10—liver cancer	2.42e-05	0.000178	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GSTA3—liver cancer	2.4e-05	0.000177	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—PSMA4—liver cancer	2.36e-05	0.000174	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—PSMD10—liver cancer	2.36e-05	0.000174	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GSTP1—liver cancer	2.36e-05	0.000174	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GOT2—liver cancer	2.35e-05	0.000173	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—HMOX1—liver cancer	2.32e-05	0.000171	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GOT2—liver cancer	2.29e-05	0.000169	CbGpPWpGaD
Fluconazole—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	2.25e-05	0.000166	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.24e-05	0.000165	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—PIK3CG—liver cancer	2.22e-05	0.000164	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—CYP2E1—liver cancer	2.21e-05	0.000163	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.21e-05	0.000163	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—PSMD10—liver cancer	2.2e-05	0.000162	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—PSMA4—liver cancer	2.2e-05	0.000162	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GSTA4—liver cancer	2.19e-05	0.000162	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GSTM1—liver cancer	2.17e-05	0.00016	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—CYP2E1—liver cancer	2.16e-05	0.000159	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—PPARG—liver cancer	2.15e-05	0.000158	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GOT2—liver cancer	2.14e-05	0.000158	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.14e-05	0.000158	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GSTA2—liver cancer	2.14e-05	0.000158	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—PIK3CA—liver cancer	2.11e-05	0.000156	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—CYCS—liver cancer	2.07e-05	0.000152	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GSTA1—liver cancer	2.06e-05	0.000152	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—CYP1A1—liver cancer	2.05e-05	0.000151	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—NAT2—liver cancer	2.04e-05	0.00015	CbGpPWpGaD
Fluconazole—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	2.03e-05	0.00015	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GOT1—liver cancer	2.03e-05	0.00015	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GGT1—liver cancer	2.03e-05	0.00015	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—CYCS—liver cancer	2.02e-05	0.000149	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—CYP2E1—liver cancer	2.01e-05	0.000149	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GOT1—liver cancer	1.98e-05	0.000146	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GGT1—liver cancer	1.98e-05	0.000146	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—PIK3CD—liver cancer	1.96e-05	0.000144	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—ALDOB—liver cancer	1.95e-05	0.000144	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.95e-05	0.000144	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—ALB—liver cancer	1.93e-05	0.000142	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—MTHFR—liver cancer	1.91e-05	0.000141	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—CYCS—liver cancer	1.88e-05	0.000139	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—PPARA—liver cancer	1.88e-05	0.000138	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—CRABP1—liver cancer	1.86e-05	0.000137	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GGT1—liver cancer	1.85e-05	0.000136	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GOT1—liver cancer	1.85e-05	0.000136	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GSTP1—liver cancer	1.82e-05	0.000134	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—HMOX1—liver cancer	1.8e-05	0.000132	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GSTP1—liver cancer	1.78e-05	0.000131	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—HMOX1—liver cancer	1.75e-05	0.000129	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—AKT1—liver cancer	1.73e-05	0.000127	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—PIK3CB—liver cancer	1.7e-05	0.000126	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GSTM1—liver cancer	1.67e-05	0.000123	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GSTP1—liver cancer	1.66e-05	0.000122	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—HMOX1—liver cancer	1.64e-05	0.000121	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GSTM1—liver cancer	1.63e-05	0.00012	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—HPGDS—liver cancer	1.63e-05	0.00012	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—PIK3CG—liver cancer	1.61e-05	0.000119	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—CYP1A1—liver cancer	1.59e-05	0.000117	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—PPARG—liver cancer	1.55e-05	0.000114	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—CYP1A1—liver cancer	1.55e-05	0.000114	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GSTM1—liver cancer	1.53e-05	0.000113	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—MTHFR—liver cancer	1.48e-05	0.000109	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—PSMA4—liver cancer	1.45e-05	0.000107	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—PSMD10—liver cancer	1.45e-05	0.000107	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—PPARA—liver cancer	1.45e-05	0.000107	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—CYP1A1—liver cancer	1.45e-05	0.000107	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—MTHFR—liver cancer	1.44e-05	0.000106	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—PPARA—liver cancer	1.42e-05	0.000104	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—PIK3CD—liver cancer	1.41e-05	0.000104	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GOT2—liver cancer	1.41e-05	0.000104	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—ALB—liver cancer	1.4e-05	0.000103	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—MTHFR—liver cancer	1.35e-05	9.95e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—CYP2E1—liver cancer	1.33e-05	9.79e-05	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—PPARA—liver cancer	1.32e-05	9.76e-05	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.3e-05	9.61e-05	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—PIK3CG—liver cancer	1.24e-05	9.17e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—CYCS—liver cancer	1.24e-05	9.16e-05	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—PIK3CB—liver cancer	1.23e-05	9.08e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GOT1—liver cancer	1.22e-05	8.99e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GGT1—liver cancer	1.22e-05	8.99e-05	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—PIK3CG—liver cancer	1.21e-05	8.95e-05	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—PPARG—liver cancer	1.2e-05	8.85e-05	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.19e-05	8.77e-05	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—PPARG—liver cancer	1.17e-05	8.63e-05	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—PIK3CG—liver cancer	1.13e-05	8.36e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GSTP1—liver cancer	1.1e-05	8.08e-05	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—PPARG—liver cancer	1.09e-05	8.07e-05	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—PIK3CD—liver cancer	1.09e-05	8.06e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—HMOX1—liver cancer	1.08e-05	7.97e-05	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—ALB—liver cancer	1.08e-05	7.95e-05	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—PIK3CD—liver cancer	1.07e-05	7.86e-05	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—ALB—liver cancer	1.05e-05	7.76e-05	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—PIK3CA—liver cancer	1.04e-05	7.66e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GSTM1—liver cancer	1.01e-05	7.42e-05	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—PIK3CD—liver cancer	9.97e-06	7.35e-05	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—ALB—liver cancer	9.84e-06	7.25e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—CYP1A1—liver cancer	9.55e-06	7.04e-05	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—PIK3CB—liver cancer	9.53e-06	7.02e-05	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—PIK3CB—liver cancer	9.3e-06	6.85e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—MTHFR—liver cancer	8.9e-06	6.56e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—PPARA—liver cancer	8.73e-06	6.44e-05	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—PIK3CB—liver cancer	8.69e-06	6.4e-05	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—AKT1—liver cancer	8.49e-06	6.26e-05	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—PIK3CA—liver cancer	7.51e-06	5.54e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—PIK3CG—liver cancer	7.48e-06	5.51e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—PPARG—liver cancer	7.22e-06	5.32e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—PIK3CD—liver cancer	6.57e-06	4.85e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—ALB—liver cancer	6.49e-06	4.78e-05	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—AKT1—liver cancer	6.14e-06	4.52e-05	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—PIK3CA—liver cancer	5.81e-06	4.28e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—PIK3CB—liver cancer	5.73e-06	4.22e-05	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—PIK3CA—liver cancer	5.67e-06	4.18e-05	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—PIK3CA—liver cancer	5.3e-06	3.9e-05	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—AKT1—liver cancer	4.74e-06	3.5e-05	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—AKT1—liver cancer	4.63e-06	3.41e-05	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—AKT1—liver cancer	4.33e-06	3.19e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—PIK3CA—liver cancer	3.49e-06	2.57e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—AKT1—liver cancer	2.85e-06	2.1e-05	CbGpPWpGaD
